Myrexis, Inc.
CompletedFormerly Myriad Pharmaceuticals, Inc.
Spin-offSpun off from Myriad GeneticsMYGNNasdaq
The two companies
Open either company's hub for its full SEC financials, ratios, ownership, filings, and every other event it's been part of.
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- —
- State of incorporation
- DE
- Record date
- —
- Distribution date
- June 30, 2009
- Ratio
- 1:4
- Parent sector
- In Vitro & In Vivo Diagnostic Substances
- Form
- 10-12B/A
- Filed
- June 8, 2009
Financials — parent vs spin-off
SEC XBRL · latest year- Revenue
- $825M
- Operating income
- −$387M
- Net income
- −$366M
- Total assets
- $707M
- Equity
- $368M
- Revenue
- —
- Operating income
- −$3M
- Net income
- −$3M
- Total assets
- $1M
- Equity
- $1M
Latest reported figures from each company's own SEC filings — the parent after the separation and the spin-off as a standalone. Full multi-year history on each company hub.
Spin-off signals
score 1/5 favorable · factors, not advice- Focus-increasingNo — both Healthcare
Spin-offs into a different sector than the parent (pure-plays) have historically outperformed diversifying ones.
- Return on capital employed-276.1%
EBIT ÷ capital employed — the quality metric the spin-off scorecard research weighs most.
- Tax-basis reportNone found
A Form 8937 (basis allocation) accompanies tax-free §355 spin-offs — favorable for taxable holders.
- Insider buying (post-spin)18 open-market buys
Officers/directors buying their own newly independent shares (Form 4) has historically preceded outperformance.
- Time since spin-off16.9 years
Studies find the spin-off return premium concentrates in roughly the first one to three years.
Factors the spin-off research literature (Greenblatt; Cusatis-Miles-Woolridge; Desai-Jain) associates with outcomes — computed from this company's own SEC filings, shown as factors, not a recommendation. The premium is debated and not guaranteed. How we compute these ↗
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.